Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%

NCT02752646 NA COMPLETED

This study will examine the tolerability and toxicity of topically applied Nepafenac 0.3% vs ketorolac 0.5% among patients undergoing cataract surgery.

Details

Lead sponsor	MDbackline, LLC
Phase	NA
Status	COMPLETED
Enrolment	200
Start date	2016-04
Completion	2017-03-01

Conditions

• Cataract

Interventions

• nepafenac 0.3%
• ketorolac

Primary outcomes

• Tolerability of nepafenac vs ketorolac — 14-28 days
  Patients will fill out a survey describing eye drop tolerability at 14-28 days

Countries

United States